Delivery Order SPE2DB24D1205-SPE2DB25FCTNW

Award Date 1/30/25
Potential Completion Date 2/21/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,458.18 firm fixed-price contract is for the provision of Inlyta 1 mg tablets, a specialty medication. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,075.39 firm fixed-price delivery order is for the supply of 4566187849 INLYTA 1 MG TABLET 180S, a prescription medication. The contract has an ultimate completion date of November 14, 2024 and was awarded on October 23, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of pharmaceutical products, specifically the 5 mg tablet form of the drug Inlyta, to support medical supply requirements. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,685.92 and a period of performance through February 15, 2024. It was awarded by the Defense Logistics...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,421.17, is for the delivery of 4566912303 INLYTA 5 MG TABLET 60S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is February 4, 2025. This award is associated with a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,039.62 firm-fixed-price delivery order is for the supply of Inlyta 5 mg tablets to support federal healthcare programs. The contract has an ultimate completion date of August 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $68,527.02 firm fixed price contract is for the delivery of the medication Inlyta 5 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,057.76 firm fixed price delivery order is for 4563432790 ! INLYTA 5 MG TABLET 60S. The contract has an ultimate completion date of February 14, 2024 and was awarded on January 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,075.39 Firm Fixed Price delivery order provides the DLA with 4,564,641,344 units of the prescription drug Inlyta 1 mg tablet. The award is associated with a larger single-award Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $22,115.01 fixed-price contract is for the delivery of Inlyta 1 mg tablets through November 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which provides a broad range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,079.24, is for the delivery of 4566135586 - INLYTA 5 MG TABLET 60S. It is a firm fixed-price delivery order contract with a completion date of November 7, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCTNW
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide 4,567,104,556 units of the 5 mg tablet form of the prescription drug Inlyta. The $11,421.17 firm fixed-price delivery order has a completion date of February 21, 2025. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. As a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, AmerisourceBergen has established itself as a critical provider of essential medical commodities, including specialty medications, generic drugs, and medical devices, across multiple therapeutic areas.

Generated 5/1/25, 9:53 AM